This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...
A new Learning Center website will launch on Monday, March 30, 2020. While the link to the new Learn...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
On December 9, 2019, the new CTS Laboratory Information System successfully implemented in Phoe...
As winter weather continues to move through parts of the US, we would like to remind you it may be n...
In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay ...